JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Price:
2.17 HKD
0.46%
Updated:
May 31, 2024
JW (Cayman) Therapeutics Co Ltd
Retained Earnings
|
JW (Cayman) Therapeutics Co Ltd
Retained Earnings Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Retained Earnings
-¥3.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Retained Earnings
-¥57.7B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Retained Earnings
-¥14.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Retained Earnings
¥8.2B
|
CAGR 3-Years
70%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Retained Earnings
¥29.1B
|
CAGR 3-Years
58%
|
CAGR 5-Years
59%
|
CAGR 10-Years
47%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Retained Earnings
¥2.2B
|
CAGR 3-Years
79%
|
CAGR 5-Years
93%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Retained Earnings?
Retained Earnings
-3.1B
CNY
-3.1B
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Retained Earnings amounts to -3.1B CNY.
What is JW (Cayman) Therapeutics Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-56%
-56%
Over the last year, the Retained Earnings growth was 0%. The average annual Retained Earnings growth rates for JW (Cayman) Therapeutics Co Ltd have been -8% over the past three years , -56% over the past five years .
You don't have any saved screeners yet
